1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is commonly used to create animal models of Parkinson disease. There is conflicting evidence on the occurrence of apoptosis induced by MPTP in the mouse substantia nigra pars compacta. We demonstrated that a single acute injection of MPTP induced apoptosis in the subventricular zone (SVZ) and rostral migratory stream (RMS) in the adult C57BL/6 mouse brain. The number of TUNEL-positive cells peaked at 24 hours after injection and decreased thereafter, paralleling the change in the number of cleaved caspase-3-positive cells after MPTP injection. Results of immunohistochemistry and ultrastructural analyses indicated that the majority of apoptotic cells in the SVZ and RMS were migrating neuroblasts (type A cells), whereas a few were astrocytes (type B cells). No apoptosis occurred in transit-amplifying progenitors (type C cells). The decrease in A cell numbers was most marked on day 2 and lasted to day 8 after the administration. A rapid and transient phagocytosis of apoptotic cells by microglial cells was demonstrated to parallel the MPTP-induced apoptosis. The present findings provide new insight into the extensive neurotoxicity of MPTP and may be valuable in reevaluating the MPTP mouse model of Parkinson disease.
INTRODUCTION
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a byproduct of the chemical synthesis of a meperidine analog with potent heroin-like effects (1) that causes damage to dopaminergic neurons and depletes dopamine in a manner similar to that seen in Parkinson disease (PD). When administered to animals, MPTP passes through the bloodYbrain barrier and is converted, mainly in glial cells, into its active form, 1-methyl-4-phenylpyridinium (MPP + ), by an enzyme, monoamine oxidase B (MAO-B) (2) . For the last 2 decades, MPTP has been widely used to generate animal models of PD in rodents and nonhuman primates. A few studies have confirmed that MPTP can induce apoptosis of dopaminergic neurons in vivo (3Y5). When injected intraperitoneally with a subacute regimen, which consists of one injection per day (30 mg/kg per day) for 5 consecutive days, MPTP induces dopaminergic cell loss by a mechanism mainly involving apoptosis (6) . The use of this subacute regimen has been the main approach to studying the apoptosis of dopaminergic cells in mice. The induction of apoptosis in mouse nigrostriatal glia has also been demonstrated with this regimen (7) , indicating that neurotoxicity of MPTP is not specifically restricted to dopaminergic neurons in the mouse brain. Furthermore, results from studies in vitro show that MPTP or MPP + induces apoptosis in primary cultured cerebellar granular neurons (8, 9) , mesencephalic dopaminergic neurons (10) , and neuroblastoma cells (11, 12) as well as PC12 cells (13, 14) .
Recently, attention has been focused on the influence of MPTP on neurogenesis (15Y17). Results from Hoglinger et al suggest that dopamine depletion in MPTP-treated mice and in patients with PD impairs the proliferation of neural precursor cells that express dopamine receptors and receive dopaminergic afferents (16) . This demonstrated the neurotoxicity of MPTP in cells in the subventricular zone (SVZ). In the adult mouse brain, the SVZ is the largest germinal region and harbors neural stem cells that retain the capacity to generate multiple cell types (18) . In adult mice, the SVZ is composed of migrating neuroblasts (type A cells), astrocytes (neural stem cells, type B cells), immature precursors (rapidly dividing transit amplifying cells, type C cells), and ependymal cells (19, 20) . Type B cells divide to give rise to clusters of type C cells, which in turn generate migrating neuroblasts (type A cells) (20) . Newly generated neuroblasts in the SVZ migrate along the rostral migratory stream (RMS) to enter the olfactory bulb (OB), where they differentiate into interneurons (21, 22) .
The multipotential progenitor cells reside in SVZ and RMS are eliminated through apoptosis to maintain a balance for proper development of the mammalian nervous system (23Y25). The mechanism of apoptotic death in the SVZ and RMS is attracting much interest and remains to be clarified. Apoptosis has been induced experimentally in the SVZ and RMS by applying extraneous insults. Hypoxia/ischemia deplete oligodendrocyte progenitors and neural stem cells in the rat perinatal SVZ through the processes of necrosis and apoptosis (26) . Nitric oxide induces apoptosis of neural progenitor cells (C17.2 line) by a mechanism requiring the activation of p38 MAP kinase, poly(ADP-ribose) polymerase, and caspase-3 (27) . A single intrauterine administration of ethyl-nitrosourea, a known DNA mutagen and neural carcinogen, triggered the apoptosis of neural precursor cells and activation of caspase-3 both in vivo (mouse embryos) and in vitro (28) . Irradiation has also been demonstrated to induce apoptosis of SVZ cells and/or dentate gyrus progenitor cells in the rat brain (29Y31). Neurogenesis occurs constitutively throughout adulthood in the SVZ and dentate gyrus, yet the rate of neurogenesis is regulated in various physiological and pathologic conditions (32) . Given these findings, it is obvious that neurogenesis in adults could be impaired through the induction by extraneous factors of apoptosis in neural progenitor cells in the SVZ. In patients with PD and MPTPtreated mice, it has been shown that numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced (16) . Although this proved to be a result of dopamine depletion, it raises the possibility that in patients with PD and animal models of PD, the impaired neurogenesis may further delay the recovery from degeneration or cell loss in the dopaminergic system. In the present study, we have obtained evidence for the induction of apoptosis by MPTP in the SVZ and RMS in the adult mouse brain, suggesting that neurotoxicity of MPTP is not specifically restricted to dopaminergic neurons in the mouse brain, although MPTP regimen-dependent differences may also exist.
MATERIALS AND METHODS

Animals and Treatments
Three-month-old male C57BL/6 mice, weighing 25 to 30 g (Clea Japan, Tokyo, Japan), were housed in a temperaturecontrolled room under a 12/12-hour light/dark cycle with ad libitum access to food and water. On the day of the experiment, mice received one intraperitoneal injection of MPTP-HCl (50 mg/kg; Sigma, St. Louis, MO) dissolved in saline; control mice received saline only. MPTP-treated and control mice were killed at defined time points after the injection under deep anesthesia. All procedures used in this study were approved by the Committee of Animal Experiments, Graduate School of Agricultural and Life Science, the University of Tokyo.
Tissue Preparation
Immediately after the brains were isolated, they were fixed in 10% neutral-buffered formalin, embedded in paraffin, and cut into 4-Km coronal or sagittal sections encompassing the entire SVZ and RMS. The sections were used for TUNEL, immunohistochemistry, and immunofluorescence histochemistry as well as for staining with hematoxylin and eosin (H&E).
Immunohistochemistry
Tissue sections were used for immunohistochemistry with the following primary antibodies: goat antidoublecortin (Dcx, 1:200; Santa Cruz Biotechnology, Santa Cruz, CA) as a marker for migrating neuroblasts (type A cells); rabbit antiglial fibrillary acidic protein (GFAP, 1:100; DAKO, Carpinteria, CA) as a marker for astrocytes (type B cells); rabbit antityrosine hydroxylase (TH, 1:100; Chemicon, Temecula, CA) as dopaminergic marker; and rabbit antiionized calcium-binding adaptor molecule1 (Iba 1, 1:250; Wako, Osaka, Japan) as a marker for microglial cells. The binding of the biotinylated secondary antibody was detected using a LSAB method with streptavidin (1:300; DAKO). The sections were visualized using 0.05% 3,3-diaminobenzidine (DAB) with 0.03% hydrogen peroxide in Tris-HCl buffer and counterstained with methyl green.
Detection of Cleaved Caspase-3 by Immunohistochemistry
Immunohistochemistry for cleaved caspase-3 was also performed by the standard procedure described previously using rabbit anticleaved caspase-3 antibody (1:100; Cell Signaling Technology, Beverly, MA). For fluorescence immunohistochemistry, after incubation with biotinylated anti-rabbit IgG antibody, specimens were reacted with Texas Red Avidin D (1:100; Vector Laboratories, Burlingame, CA), and examined using a Zeiss LSM510 confocal laser scanning microscope.
Double-Labeling Immunofluorescence
To determine the phenotype of the cells undergoing apoptosis, double-labeling immunofluorescence histochemistry was performed using the anticleaved caspase-3 antibody and either the goat anti-Dcx or rabbit anti-GFAP antibody described previously or mouse antiepidermal growth factor receptor (EGFR, 1:50; DAKO) or mouse anti-Lewis X (LeX, clone MMA, also known as ssea-1 or CD15, 1:50; BD Bioscience, Heidelberg, Germany) as a marker for transitamplifying precursors (type C cells). After visualization with Texas red-conjugated anti-rabbit antibody (1:100; Vector Laboratories), tissue sections were incubated with an Avidin/ Biotin Blocking Kit (Vector Laboratories) and then with another primary antibody. Visualization of the cell markers was accomplished using FITC-conjugated species-specific secondary antibodies: FITC-conjugated donkey anti-goat IgG, FITC-conjugated goat anti-rabbit IgG (1:100; Santa Cruz Biotechnology), and FITC-conjugated goat anti-mouse IgG (1:100; Vector Laboratories). Sections were mounted with Vectashield (Vector Laboratories) and observed using the Zeiss LSM510 confocal laser scanning microscope.
TUNEL Method
Tissue sections were processed for fluorescence TUNEL staining by using the ApopTag Fluorescein In Situ Apoptosis Detection Kit and an ApopTag peroxidase In Situ Apoptosis Detection Kit (Chemicon) according to the manufacturer's instructions.
TUNEL Double-Labeling Immunofluorescence
Subsequent to visualization of the fragmented DNA using the fluorescent TUNEL method, sections were incubated in 10% normal goat serum and 0.40% Triton X-100 in phosphate-buffered saline (PBS) for 1 hour at room temperature. A rabbit monoclonal anti-Iba 1 antibody was then applied overnight. After being washed in PBS, sections were incubated with a biotinylated secondary goat anti-rabbit IgG antibody (1:100; Vector Laboratories) for 1 hour at room temperature followed by Texas red-avidin D for 1 hour at room temperature. Sections were then mounted with Vectashield and observed using the Zeiss LSM510 confocal laser scanning microscope.
Electron Microscopic Observation
The brain samples were immediately removed and fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer, postfixed in 1.0% osmium tetroxide/0.1 M phosphate buffer, and embedded in Epon 812. Ultrathin sections of the areas of interest were cut with a diamond knife, double-stained with uranyl acetate and lead citrate, and examined under the JEM-1200EX electron microscope (JEOL) at 60 kV.
Cell Counting and Statistics
Serial brain coronal sections through the SVZ corresponding to bregma from 0.50 to 0.98 mm (anteriorYposterior coordinate) were collected with the aid of the mouse brain atlas (33) . At least one of every 15 sections (total 5 to 7 sections per animal) was blindly counted for quantitative analysis on DAB-stained (cells positive for TUNEL, cleaved caspase-3, GFAP, Dcx, or Iba 1) sections. Results were expressed as the average number in the unilateral SVZ and reported as the mean T standard deviation. The Student t-test was used to assess differences between data groups. Differences were considered statistically significant of p G 0.05.
RESULTS
Induction of Apoptosis After a Single Injection of MPTP Histologic Findings
The criteria defined by nuclear condensation (pyknosis) and nuclear fragmentation (karyorrhexis) were used to identify apoptotic cell death in H&E-stained, paraffinembedded sections. Numerous apoptotic bodies were observed in the forebrain of C57BL/6 mice 24 hours after the administration of MPTP (Fig. 1) , but none in the salineadministered controls. The induction of apoptosis by MPTP was restricted to the SVZ (Fig. 1B) , RMS (Fig. 1C, D) , and OB (Fig. 1E, F) . No such changes were found in any other regions of the brain. 
TUNEL Assay
Distribution of Cleaved Caspase-3
Immunohistochemical staining for cleaved caspase-3 demonstrated a marked increase in reactivity in the SVZ and RMS at 24 hours after MPTP was administered, paralleling 
Ultrastructural Demonstration of Apoptosis
Electron microscopy of brain tissues obtained from MPTPtreated mice revealed cells in the SVZ and RMS with ultrastructural characteristic of the early to midstages of apoptosis, including dense aggregates of chromatin and apoptotic bodies (Fig. 3A, B) . Cells in advanced stages of apoptotic death exhibited marked chromatin condensation and cellular shrinkage with or without disruption of the plasma membrane (Fig. 3CYF) . 
Evidence for Phagocytosis of Apoptotic Bodies by Microglial Cells
Immunohistochemical findings demonstrated that activation and infiltration of microglial cells occurred in the SVZ and RMS of MPTP-treated mice. Marked increases in the number of Iba 1 + cells were observed in the SVZ (Fig. 4A ) and RMS (Fig. 5A) . The peak in the number of microglial cells in the SVZ was observed at 24 hours after MPTP injection (Fig. 4B) , paralleling that of apoptotic cells and suggesting the increase in microglial cells is a response to MPTP-induced apoptosis. Activated microglial cells were clearly observed in the RMS (Fig. 5B) . Ultrastructural analysis demonstrated that the phagocytosis of apoptotic bodies by microglial cells occurred in the SVZ (Fig. 4C) and RMS ( 
Phenotype of Cells Undergoing Apoptosis in the Subventricular Zone and Rostral Migratory Stream
Figures 6A and 6B show that the majority of cells expressing Dcx (a marker for migrating neuroblasts, A cells) are positive for cleaved caspase-3 in the SVZ (Fig. 6A) and RMS (Fig. 6B) . A few cells expressing cleaved caspase-3 were also stained with GFAP (a marker for astrocytes, B cells) (SVZ, Fig. 6C; RMS, Fig. 6D ). No EGFR + (SVZ, Fig. 6E ; RMS, Fig. 6F ) or LeX + cells (SVZ, Fig. 6G ; RMS, Fig. 6H ) were observed to express cleaved caspase-3. It has been demonstrated that the EGFR + /GFAP j or LeX + /GFAP j cells corresponded to transit-amplifying, multipotent type C cells in the adult SVZ, and some C cells were also found in the RMS (18, 34) . Although a small subset of B cells expressed EGFR, they apparently were in contact with the lateral ventricle (18) . Cleaved caspase-3 was not expressed by any C cells. To validate the findings of cleaved caspase-3 doublelabeling with cell markers, we performed an ultrastructural analysis. Distinct cell types were identified according to the criteria defined by Doetsch et al (19) . As shown in Figures 3A  and 3B , cells that were in the early stage of apoptotic death exhibited the ultrastructural characteristics of A cells: an open pericellular space, a scant and dark cytoplasm, and smooth contours. Cells that were at an advanced stage of apoptotic death were observed adjacent to A cells (Fig. 3B, C, E, F, a) , located close to C cells. C cell has an irregular nucleus with deep invaginations and mostly lax chromatin and has a typical, large reticulated nucleolus (Fig. 3A, B, E, F, c) . These observations together with the findings of cleaved caspase-3 double-staining suggest that the majority of cells undergoing apoptosis are A cells, that is, migrating neuroblasts.
Dcx+ Cell Numbers Are Decreased After MPTP Injection
The occurrence of apoptosis in A cells is thought to be followed by a loss of A cells. To test this hypothesis, we labeled brain sections with antibody against Dcx, a marker of migrating neuroblasts. In the SVZ, there was a 65.2%, 37.1%, and 24.3% reduction of A cells at 2, 4, and 8 days after MPTP injection, respectively (Fig. 7A, C) . The same changes were also observed in the RMS (Fig. 7B) . GFAP + B cell number were not significantly reduced at any time point, indicating apoptotic death occurred in very few B cells (Fig. 8) . We also observed a significant (26.2% and 31.9%) increase in B cells in the SVZ at 4 and 8 days after MPTP injection, respectively (Fig. 8A, C) . This may be the result of a response to the loss of A cells.
Reduction of Dopaminergic Fibers in Striatum
To determine whether the MPTP regimen used here simultaneously produces striatal dopamine depletion, we performed an immunohistochemistry study with an antibody raised against tyrosine hydroxylase (TH), the rate-limiting enzyme in the synthesis of dopamine. MPTP-treated mice exhibited patterns of TH-immunoreactive fiber loss (Fig. 9) , which was particularly apparent at 3 and 4 days after MPTP lesion when compared with saline control.
DISCUSSION
In the present study, a single injection of MPTP produced a rapid and profound loss in dopaminergic fibers (THimmunoreactive) in the striatum at day 1, which was maximal at 3 and 4 days after MPTP administration, suggesting this regimen could also induce biochemical changes in nigralYstriatal dopamine system similar to the findings with other regimens such as acute or subacute regimen.
This study is the first to demonstrate that a single injection of MPTP-induced apoptotic cell death in the SVZ and RMS in a mouse model of PD. The cell death was observed 12 to 48 hours after an intraperitoneal injection with a peak at 24 hours as detected by TUNEL and immunohistochemistry for cleaved caspase-3. Ultrastructural findings supported the occurrence of apoptosis in the SVZ and RMS. The majority of cells dying in the SVZ and RMS were Dcx-immunoreactive migrating neuroblasts. A few were GFAP-immunoreactive and identified as astrocytes. Cells expressing cleaved caspase-3 were not labeled with EGFR or LeX. Furthermore, the present study demonstrated that MPTP-induced apoptosis was followed by a 65.2%, 37.1%, and 24.3% reduction in the number of Dcximmunoreactive cells by 2, 4, and 8 days, respectively, confirming that the induction of apoptosis by a single dose of MPTP contributes to the loss of Dcx-immunoreactive cells (i.e. migrating neuroblasts).
The apoptosis of the cells in the SVZ and RMS is further supported by the prominent phagocytosis of fragmented DNA by microglial cells detected using a doublelabeling method with TUNEL and a marker for microglial cells as well as ultrastructural analysis. TUNEL-positive microglial cells were observed throughout the cytoplasm, including the protrusions, but often had an intact nucleus, suggesting that these cells have indeed phagocytosed dying apoptotic cells in the SVZ and RMS rather than undergoing apoptosis themselves (35) . Moreover, in the present study, the infiltration and activation of microglial cells in the SVZ and RMS paralleled the ongoing apoptosis. The number of microglial cells in the SVZ peaked at 24 hours and then decreased, reaching the control level at 4 days after the administration of MPTP. These observations suggest that the microglial infiltration and activation in the SVZ and RMS are partially attributable to the time course of MPTP-induced apoptosis in these areas. Caspase-3 is one of the key executioners of apoptosis, being either partially or totally responsible for the proteolytic cleavage of many important proteins (36) . In the present study, based on the findings of immunohistochemical staining for cleaved caspase-3, a time-dependent activation of caspase-3 in response to acute MPTP toxicity was observed that is consistent with the findings of the TUNEL assay, indicating that the activation of caspase-3 is correlated with the induction of apoptotic death in the SVZ and RMS. Duan et al suggested that immunohistochemical stains such as the cleaved caspase-3 stain could improve the detection and quantification of apoptosis in tissue sections compared with the TUNEL assay (37) . To phenotype the apoptotic cells, we performed TUNEL double-staining, but found that the majority of TUNEL-positive cells did not express cellular markers. This could be attributable to the downregulation of markers in dying cells (38) ; therefore, we performed immunofluorescence double-labeling with antibody for cleaved caspase-3 and different cell markers instead of TUNEL double-staining.
The SVZ in adult mice contains 3 distinct cell types: migrating neuroblasts (type A cells), astrocytes (type B cells), and novel putative precursor cells (type C cells) (19) . B cells as neural stem cells express GFAP and give rise to the rapidly dividing, transit-amplifying C cells that generate A cells (20, 39) . A cells correspond to proliferating, migrating neuronal precursors (19, 40) and join an extensive tangential network of pathways for chain migration that feeds into the RMS leading to the OB (22) . In the present study, the majority of cells undergoing apoptosis in the SVZ and RMS were identified as migrating neuroblasts (A cells) based on immunofluorescence double-labeling of cleaved caspase-3 and Dcx, and ultrastructural analysis. Dcx is a neuron-specific microtubule-associated protein expressed in newly mitotic neurons and has been used as a marker for migrating neuroblasts (41Y43). Ultrastructural analysis in the present study shows that the cells undergoing apoptosis in the SVZ are separated by an open pericellular space. They adhered to the adjacent nonapoptotic cells that have an ovalshaped dark nucleus, scant and dark cytoplasm, smooth contours, and were morphologically similar to migrating neuroblasts according to the criteria defined by Doetsch et al (19) . Moreover, both the apoptotic and nonapoptotic cells were located close to C cells, which have an irregular nucleus with deep invaginations, mostly lack chromatin, and have a typical large reticulated nucleolus. The significant and rapid decrease in the numbers of Dcx-immunoreactive cells caused by MPTP in the present study further supports that the majority of cells undergoing apoptosis were A cells. Although A cells are particularly susceptible to MPTP (in contrast with B and C cells), the cellular mechanism by which MPTP induces their apoptosis remains to be clarified.
Type A cells leave the SVZ and migrate along the RMS to the OB where they move radially away from the RMS and differentiate into granule and periglomerular neurons (21, 22, 44, 45) . The decrease in the numbers of migrating neuroblasts induced by MPTP may cause an impairment of neurogenesis. However, we observed an increase in GFAP+ cells (type B cells) in SVZ at 4 and 8 days after MPTP injection. The adult neural stem cells possess a self-renewing capacity (25) and, as mentioned in the BIntroduction[, B cells will ultimately give rise to the migrating neuroblasts (type A cells); we thus speculated that there will be a recovery from the loss of A cells induced by MPTP. It will be interesting to further clarify 1) whether and how increased type B cells contribute to newborn A cells; and 2) whether this recovery requires long-term effort or impaired neurogenesis by MPTP is a transient event. Although an increase in type C cells was not detectable by immunohistochemical analysis at 8 days after MPTP injection (data not shown), we do not rule out the possibility that type C cells proliferate after an increase in type B cells. Further studies need to be performed with the aid of triple immunofluorescence and electron microscopic analysis (38) as well as at time points later than 8 days after MPTP injection.
In summary, although regimen-dependent differences may exist and remain to be investigated, apoptosis does occur in the SVZ and RMS in single-dose MPTPtreated mice. The majority of cells undergoing apoptosis were identified as migrating neuroblasts, although a few were astrocytes. No apoptotic death was observed in transit-amplifying C cells. As an extensively used animal model of PD, the MPTP-treated mouse provides an important tool to help researchers better evaluate and understand the pathogenesis of PD. The data demonstrated here may provide new insights into the MPTP mouse model of PD.
